VKTX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Viking Therapeutics, Inc.
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Viking Therapeutics, Inc. for potential securities fraud violations. This follows a significant stock price increase after positive trial data for their anti-obesity drug was released.
November 20, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Viking Therapeutics is under investigation for potential securities fraud following a stock price surge due to positive trial data for their anti-obesity drug.
The investigation into potential securities fraud could negatively impact investor confidence and lead to a short-term decline in Viking Therapeutics' stock price, despite the recent positive trial data.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100